|
,|
TABLE OF CONTENT| |
Part |I: | Basic |Immunologic | Mechanisms
1. | Highlights |of | Innate |and | Adaptive |Immune |Systems
2. | Soluble | Mediators |of |the | Immune |System
3. | Antigens |and |Antibodies
4. | Cellular |Activities |and |Clinical |Disorders |of | Innate |and | Adaptive |Immunity
Part |II: |The | Theory |of |Immunologic | and |Serologic |Procedures
5. | Basic |Safety |in | the | Immunology-Serology |Laboratory
6. |Quality |Assurance |and |Quality |Control |Practices
7. | Basic |Serologic |Laboratory: |Techniques |and | Clinical |Applications
8. | Precipitation |and |Particle |Agglutination | Methods
9. | Electrophoresis |Techniques
10. |Labeling |Techniques |in | Immunoassay
11. |Flow |Cytometry
12. |Molecular |Laboratory |Techniques
Part |III: | Immunologic | Manifestations |of |Infectious |Diseases
13. |Infectious |Diseases: |Overview |& | TORCH |Diseases
14. |Streptococcal |Infections
15. |Syphilis
16. |Vector-Borne |Diseases
17. |Infectious | Mononucleosis
18. |Viral |Hepatitis
Part |IV: | Immune | Disorders
19. |Primary |and |Acquired |(Secondary) |Immune |Deficiencies
20. |Hypersensitivity |Reactions
21. |Immunoproliferative | Disorders
22. |Tolerance, |Autoimmunity |and |Autoimmune |Disorders
23. |Systemic |Lupus |Erythematosus
,|
24. |Rheumatoid | Arthritis
Part |V: |Transplantation |& |Tumor |Immunology
25. |Transplantation: |HLA, | Solid |Organ, |and |Hematopoietic |Stem |Cells
26. |Tumor | Immunology |and | Up-to-Date |Applications |of | Next |Generation |Sequencing
Part |VI: | Vaccines
27. |Primer |on | Vaccines
Chapter 01: Highlights of the Innate and Adaptive Immune Systems
| | | | | | | | |
MULTIPLE |CHOICE
1. | The |―father‖ |of |immunology|is |generally|considered |to |be
a. | Koch.
b. | Pasteur.
c. | Gram.
d. | Salk.
ANS: | B
,|
Louis |Pasteur |is |generally |considered |to |be |the |―father |of |immunology.‖
DIF: | Cognitive |Level: |I
2. | An |early |form |of |immunization |was |practiced |by |the
a.| Romans.
b.| Greeks.
c.| Chinese.
d.| Native |Americans.
ANS: | C
Beginning |about |1000 |AD, |the |Chinese |practiced |a |form |of |immunization |by |inhaling |dried
powders |derived | from |the |crusts |of |smallpox |lesions.
DIF: | Cognitive |Level: |I
3. | A |specific |function |of |the |immune |system |is |to
a. | recognize |self |from |nonself.
b. | defend |the |body |against | nonself.
c. | amplify |specific |functions.
d. | Both |A |and | B.
ANS: | D
The |function |of |the |immune |system |is |to |recognize |self |from |nonself |and |defend |the |body
against |nonself. |Such |a |system |is | necessary |for |survival. |The |immune |system |also |has
nonspecific |effector |mechanisms |that |usually |amplify |the |specific |functions. |Nonspecific
components |of |the |immune |system |include | mononuclear |phagocytes, |polymorphonuclear
leukocytes, |and |soluble |factors |(e.g., |complement).
DIF: | Cognitive |Level: |I
4. | An |undesirable |consequence |of |immunity |is
a.| natural |resistance.
b.| acquired | resistance |to |infectious |diseases.
,|
TABLE OF CONTENT| |
Part |I: | Basic |Immunologic | Mechanisms
1. | Highlights |of | Innate |and | Adaptive |Immune |Systems
2. | Soluble | Mediators |of |the | Immune |System
3. | Antigens |and |Antibodies
4. | Cellular |Activities |and |Clinical |Disorders |of | Innate |and | Adaptive |Immunity
Part |II: |The | Theory |of |Immunologic | and |Serologic |Procedures
5. | Basic |Safety |in | the | Immunology-Serology |Laboratory
6. |Quality |Assurance |and |Quality |Control |Practices
7. | Basic |Serologic |Laboratory: |Techniques |and | Clinical |Applications
8. | Precipitation |and |Particle |Agglutination | Methods
9. | Electrophoresis |Techniques
10. |Labeling |Techniques |in | Immunoassay
11. |Flow |Cytometry
12. |Molecular |Laboratory |Techniques
Part |III: | Immunologic | Manifestations |of |Infectious |Diseases
13. |Infectious |Diseases: |Overview |& | TORCH |Diseases
14. |Streptococcal |Infections
15. |Syphilis
16. |Vector-Borne |Diseases
17. |Infectious | Mononucleosis
18. |Viral |Hepatitis
Part |IV: | Immune | Disorders
19. |Primary |and |Acquired |(Secondary) |Immune |Deficiencies
20. |Hypersensitivity |Reactions
21. |Immunoproliferative | Disorders
22. |Tolerance, |Autoimmunity |and |Autoimmune |Disorders
23. |Systemic |Lupus |Erythematosus
,|
24. |Rheumatoid | Arthritis
Part |V: |Transplantation |& |Tumor |Immunology
25. |Transplantation: |HLA, | Solid |Organ, |and |Hematopoietic |Stem |Cells
26. |Tumor | Immunology |and | Up-to-Date |Applications |of | Next |Generation |Sequencing
Part |VI: | Vaccines
27. |Primer |on | Vaccines
Chapter 01: Highlights of the Innate and Adaptive Immune Systems
| | | | | | | | |
MULTIPLE |CHOICE
1. | The |―father‖ |of |immunology|is |generally|considered |to |be
a. | Koch.
b. | Pasteur.
c. | Gram.
d. | Salk.
ANS: | B
,|
Louis |Pasteur |is |generally |considered |to |be |the |―father |of |immunology.‖
DIF: | Cognitive |Level: |I
2. | An |early |form |of |immunization |was |practiced |by |the
a.| Romans.
b.| Greeks.
c.| Chinese.
d.| Native |Americans.
ANS: | C
Beginning |about |1000 |AD, |the |Chinese |practiced |a |form |of |immunization |by |inhaling |dried
powders |derived | from |the |crusts |of |smallpox |lesions.
DIF: | Cognitive |Level: |I
3. | A |specific |function |of |the |immune |system |is |to
a. | recognize |self |from |nonself.
b. | defend |the |body |against | nonself.
c. | amplify |specific |functions.
d. | Both |A |and | B.
ANS: | D
The |function |of |the |immune |system |is |to |recognize |self |from |nonself |and |defend |the |body
against |nonself. |Such |a |system |is | necessary |for |survival. |The |immune |system |also |has
nonspecific |effector |mechanisms |that |usually |amplify |the |specific |functions. |Nonspecific
components |of |the |immune |system |include | mononuclear |phagocytes, |polymorphonuclear
leukocytes, |and |soluble |factors |(e.g., |complement).
DIF: | Cognitive |Level: |I
4. | An |undesirable |consequence |of |immunity |is
a.| natural |resistance.
b.| acquired | resistance |to |infectious |diseases.
